Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 214 entries
View as:

Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02457910 Org: User:
Start: 06/30/15 End: 08/08/22 Due: 08/08/23

Opioid Titration in the Hospice Setting: Barriers Assessment and Modification of the Model Order Sheet and Protocol

Phase: N/A Priority: Normal
NCT ID: NCT01230515 Org: User:
Start: 01/31/06 End: 03/31/08 Due: 03/31/09

Internal Radiation Therapy in Treating Patients With Primary Liver Cancer That Cannot Be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00469963 Org: User:
Start: 12/31/03 End: 04/30/07 Due: 04/30/08

Study of Anxiety and Avoidance of Others in Patients Previously Treated for Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00483639 Org: User:
Start: 11/30/03 End: 01/31/08 Due: 01/31/09

Studying Health Outcomes After Treatment in Patients With Retinoblastoma

Phase: N/A Priority: Normal
NCT ID: NCT03932786 Org: User:
Start: 01/24/19 End: 01/31/31 Due: 01/31/32

Sorafenib and Erlotinib in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00837876 Org: User:
Start: 10/31/08 End: 11/30/12 Due: 11/30/13

Trastuzumab Plus Docetaxel in Treating Women With Recurrent or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00006104 Org: User:
Start: 09/30/98 End: 07/31/03 Due: 07/31/04

Home-Based Lymphedema Care Program (HBLCP) in Improving Lymphedema Self-Care in Head and Neck Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT02170272 Org: User:
Start: 06/30/14 End: 10/31/17 Due: 10/31/18

Evaluating the Use of Dual Imaging Techniques for Detection of Disease in Patients with Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05945875 Org: User:
Start: 10/03/23 End: 12/31/28 Due: 12/31/29

Navigation Endoscopy to Reach Indeterminate Lung Nodules Versus Trans-Thoracic Needle Aspiration

Phase: N/A Priority: Normal
NCT ID: NCT04250194 Org: User:
Start: 05/22/20 End: 07/31/25 Due: 07/31/26

Role of Biomarkers in Muscle Pain and Joint Pain in Patients With Solid Tumors Receiving Paclitaxel

Phase: N/A Priority: Normal
NCT ID: NCT01096407 Org: User:
Start: 11/30/09 End: 11/30/10 Due: 11/30/11

PET Study in Patients With Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00712556 Org: User:
Start: 05/31/08 End: 03/31/09 Due: 03/31/10

A 2-Week Ketogenic Diet in Combination With Letrozole to Modulate PI3K Signaling in ER+ Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03962647 Org: User:
Start: 07/08/19 End: 07/14/24 Due: 07/14/25

Opioids Titration in Hospice Patients

Phase: N/A Priority: Normal
NCT ID: NCT01007422 Org: User:
Start: 06/30/08 End: 05/31/09 Due: 05/31/10

Yoga Intervention in Supporting Children With Cancer and Their Parents During Chemotherapy Infusion

Phase: N/A Priority: Normal
NCT ID: NCT04034914 Org: User:
Start: 08/07/19 End: 06/30/20 Due: 06/30/21

Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00987766 Org: User:
Start: 11/30/09 End: 10/31/16 Due: 10/31/17

Image-Based, In-Vivo Assessment of Tumor Hypoxia to Guide Hypoxia-Driven Adaptive Radiation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05996432 Org: User:
Start: 05/17/23 End: 05/31/29 Due: 05/31/30

Ibrutinib in Treating Patients With Refractory or Relapsed Lymphoma After Donor Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT02869633 Org: User:
Start: 11/30/16 End: 10/31/23 Due: 10/31/24

Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00680758 Org: User:
Start: 05/31/08 End: 12/31/10 Due: 12/31/11

Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00514020 Org: User:
Start: 08/31/07 End: 02/28/11 Due: 02/28/12

Yoga Intervention in Head and Neck Cancer Patients Undergoing Concurrent Chemo-Radiation

Phase: N/A Priority: Normal
NCT ID: NCT04146779 Org: User:
Start: 10/28/19 End: 10/06/20 Due: 10/06/21

Safety and Efficacy of Avelumab in Small Intestinal Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03000179 Org: User:
Start: 03/03/17 End: 08/03/21 Due: 08/03/22

Tumor-Treating Fields Therapy in Preventing Brain Tumors in Participants With Extensive-Stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03607682 Org: User:
Start: 09/05/18 End: 07/13/20 Due: 07/13/21

Evaluating Impact of NIRAF Detection for Identifying Parathyroid Glands During Parathyroidectomy

Phase: N/A Priority: Normal
NCT ID: NCT04299425 Org: User:
Start: 03/13/20 End: 03/03/23 Due: 03/03/24

Pevonedistat and Azacitidine in MDS or MDS/MPN Patients Who Fail Primary Therapy With DNA Methyl Transferase Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT03238248 Org: User:
Start: 08/07/17 End: 11/27/23 Due: 11/27/24